The ACTIVE magnetic stimulation chair achieves thousands of contractions of the pelvic floor muscles, improving their tone and restoring neuromuscular control of the area while the patient remains comfortably seated.

How does a urinary incontinence chair work?

The chair uses a focused magnetic field to deeply and completely painlessly stimulate the pelvic floor muscles. The patient simply sits—without needing to undress—while thousands of muscle contractions are generated per session, similar to Kegel exercises but at a supramaximal intensity, impossible to achieve voluntarily.

It is a minimally invasive and painless treatment; you should feel your pelvic floor contractions. This will help you become more aware of your pelvic muscles and perform Kegel exercises more effectively at home. These exercises complement the incontinence treatment you are currently undergoing.

How long does the session last and how many sessions are needed?

Generally, a protocol of 6 to 8 sessions of 28 minutes each (2 per week) is recommended. However, the frequency and duration of treatment can be adjusted according to each patient's needs after a personalized medical assessment.

At the end of the treatment, your doctor will re-evaluate you to assess the need for additional sessions, complementary treatments, or to conclude the pelvic floor therapy. Some patients may require follow-up or maintenance sessions to ensure the long-term effectiveness of the treatment.

How should I prepare for the sessions?

No preparation is necessary before the sessions, although we recommend wearing comfortable clothing. This treatment requires no recovery time, and you can return to your daily activities immediately after the procedure.

Considerations

It is important that a healthcare professional evaluate the patient to determine if the ACTIVE chair is a suitable treatment for their specific case. Although it is a minimally invasive treatment, there are some contraindications for treating urinary incontinence with the chair:

• Pregnancy, even in the first weeks of gestation.
• Pacemaker, implanted defibrillator or neurostimulator.
• Electronic implants.
• Pulmonary insufficiency, respiratory distress, and severe chronic asthma.
• Metallic implants of any type in the pelvic, femoral or sacral area.
• At the vascular level, “aortic stents” and other devices of metallic origin.
• Hemorrhagic pathologies and anticoagulant therapies as a precaution.
• Active malignant tumor in the pelvic area.
• Fever or genital infections.
• copper IUD.